Eric Lalanne
Directeur/Membre du Conseil chez Oryzon Genomics Diagnóstico SL
Profil
Eric Lalanne is currently a Director at Oryzon Genomics Diagnóstico SL.
He previously worked as a Director-In Vitro Diagnostics at Oryzon Genomics SA. Lalanne holds a doctorate degree from Université Paris 1 Panthéon-Sorbonne and undergraduate and graduate degrees from Université Toulouse III - Paul Sabatier.
Postes actifs de Eric Lalanne
| Sociétés | Poste | Début |
|---|---|---|
Oryzon Genomics Diagnóstico SL
 Oryzon Genomics Diagnóstico SL Medical SpecialtiesHealth Technology Oryzon Genomics Diagnóstico SL develops oncology diagnostic solutions. It operates as a IVD company that engages in developing and commercializing molecular diagnostics for oncology. The firm's product GynEC-DX, a molecular test for endometrial cancer detection. The company was founded in 2013 and is headquartered in Barcelona, Spain. | Directeur/Membre du Conseil | - |
Anciens postes connus de Eric Lalanne
| Sociétés | Poste | Fin |
|---|---|---|
| ORYZON GENOMICS S.A. | Corporate Officer/Principal | - |
Formation de Eric Lalanne
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
| Université Toulouse III - Paul Sabatier | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Oryzon Genomics Diagnóstico SL
Oryzon Genomics Diagnóstico SL Medical SpecialtiesHealth Technology Oryzon Genomics Diagnóstico SL develops oncology diagnostic solutions. It operates as a IVD company that engages in developing and commercializing molecular diagnostics for oncology. The firm's product GynEC-DX, a molecular test for endometrial cancer detection. The company was founded in 2013 and is headquartered in Barcelona, Spain. | Health Technology |